Cargando…
Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms
Growing evidence highlights the endocannabinoid (EC) system involvement in cancer progression. Lipid mediators of this system are secreted by hematopoietic cells, including the ECs 2-arachidonoyl-glycerol (2AG) and arachidonoyl-ethanolamide (AEA), the 2AG metabolite 1AG, and members of N-acylethanol...
Autores principales: | Forte, Dorian, Fanelli, Flaminia, Mezzullo, Marco, Barone, Martina, Corradi, Giulia, Auteri, Giuseppe, Bartoletti, Daniela, Martello, Marina, Ottaviani, Emanuela, Terragna, Carolina, Curti, Antonio, Pagotto, Uberto, Palandri, Francesca, Cavo, Michele, Catani, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246996/ https://www.ncbi.nlm.nih.gov/pubmed/32403407 http://dx.doi.org/10.3390/ijms21093399 |
Ejemplares similares
-
Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism
por: Fanelli, Flaminia, et al.
Publicado: (2018) -
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis
por: Barone, Martina, et al.
Publicado: (2020) -
The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: “Crafting” a Microenvironment That Matters
por: Catani, Lucia, et al.
Publicado: (2021) -
Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
por: Tsuboi, Kazuhito, et al.
Publicado: (2018) -
Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
por: Smaga, Irena, et al.
Publicado: (2014)